Literature DB >> 24272679

Abnormalities in glycogen metabolism in a patient with alpers' syndrome presenting with hypoglycemia.

Mariella Simon1, Richard C Chang, Deeksha S Bali, Lee-Jun Wong, Ying Peng, Jose E Abdenur.   

Abstract

Intermittent hypoglycemia has been described in association with Alpers' syndrome, a disorder caused by mutations in the mitochondrial DNA polymerase gamma gene. In some patients hypoglycemia may define the initial disease presentation well before the onset of the classical Alpers' triad of psychomotor retardation, intractable seizures, and liver failure. Correlating with the genotype, POLG pathogenicity is a result of increased mitochondrial DNA mutability, and mitochondrial DNA depletion resulting in energy deficient states. Hypoglycemia therefore could be secondary to any metabolic pathway affected by ATP deficiency. Although it has been speculated that hypoglycemia is due to secondary fatty acid oxidation defects or abnormal gluconeogenesis, the exact underlying etiology is still unclear. Here we present detailed studies on carbohydrate metabolism in an Alpers' patient who presented initially exclusively with intermittent episodes of hypoglycemia and ketosis. Our results do not support a defect in gluconeogenesis or fatty acid oxidation as the cause of hypoglycemia. In contrast, studies performed on liver biopsy suggested abnormal glycogenolysis. This is shown via decreased activities of glycogen brancher and debrancher enzymes with normal glycogen structure and increased glycogen on histology of the liver specimen. To our knowledge, this is the first report documenting abnormalities in glycogen metabolism in a patient with Alpers' syndrome.

Entities:  

Year:  2013        PMID: 24272679      PMCID: PMC4213341          DOI: 10.1007/8904_2013_280

Source DB:  PubMed          Journal:  JIMD Rep        ISSN: 2192-8304


  33 in total

1.  Identification of the catalytic residues of bifunctional glycogen debranching enzyme.

Authors:  A Nakayama; K Yamamoto; S Tabata
Journal:  J Biol Chem       Date:  2001-05-25       Impact factor: 5.157

2.  Mitochondrial DNA polymerase gamma mutations: an ever expanding molecular and clinical spectrum.

Authors:  Sha Tang; Jing Wang; Ni-Chung Lee; Margherita Milone; Michelle C Halberg; Eric S Schmitt; William J Craigen; Wei Zhang; Lee-Jun C Wong
Journal:  J Med Genet       Date:  2011-08-31       Impact factor: 6.318

3.  Mitochondrial DNA mutations induce mitochondrial dysfunction, apoptosis and sarcopenia in skeletal muscle of mitochondrial DNA mutator mice.

Authors:  Asimina Hiona; Alberto Sanz; Gregory C Kujoth; Reinald Pamplona; Arnold Y Seo; Tim Hofer; Shinichi Someya; Takuya Miyakawa; Chie Nakayama; Alejandro K Samhan-Arias; Stephane Servais; Jamie L Barger; Manuel Portero-Otín; Masaru Tanokura; Tomas A Prolla; Christiaan Leeuwenburgh
Journal:  PLoS One       Date:  2010-07-07       Impact factor: 3.240

4.  Glucose metabolism and diet-based prevention of liver dysfunction in MPV17 mutant patients.

Authors:  Rossella Parini; Francesca Furlan; Luigi Notarangelo; Antonella Spinazzola; Graziella Uziel; Pietro Strisciuglio; Daniela Concolino; Carlo Corbetta; Gabriella Nebbia; Francesca Menni; Giorgio Rossi; Marco Maggioni; Massimo Zeviani
Journal:  J Hepatol       Date:  2008-10-31       Impact factor: 25.083

Review 5.  Hypoglycemia in infants and children.

Authors:  M W Haymond
Journal:  Endocrinol Metab Clin North Am       Date:  1989-03       Impact factor: 4.741

6.  Two novel POLG mutations causing hepatic mitochondrial DNA depletion with recurrent hypoketotic hypoglycaemia and fatal liver dysfunction.

Authors:  B Bortot; E Barbi; S Biffi; G Lunazzi; R Bussani; A Burlina; S Norbedo; A Ventura; M Carrozzi; G M Severini
Journal:  Dig Liver Dis       Date:  2009-02-04       Impact factor: 4.088

7.  Multiple oxidative phosphorylation deficiencies in severe childhood multi-system disorders due to polymerase gamma (POLG1) mutations.

Authors:  Maaike C de Vries; Richard J Rodenburg; Eva Morava; Edwin P M van Kaauwen; Henk ter Laak; Reinier A Mullaart; Irina N Snoeck; Peter M van Hasselt; Peter Harding; Lambert P W van den Heuvel; Jan A M Smeitink
Journal:  Eur J Pediatr       Date:  2006-09-07       Impact factor: 3.860

8.  Low glucose under hypoxic conditions induces unfolded protein response and produces reactive oxygen species in lens epithelial cells.

Authors:  R Elanchezhian; P Palsamy; C J Madson; M L Mulhern; D W Lynch; A M Troia; J Usukura; T Shinohara
Journal:  Cell Death Dis       Date:  2012-04-19       Impact factor: 8.469

9.  Mitochondrial mosaics in the liver of 3 infants with mtDNA defects.

Authors:  Frank Roels; Patrick Verloo; François Eyskens; Baudouin François; Sara Seneca; Boel De Paepe; Jean-Jacques Martin; Valerie Meersschaut; Marleen Praet; Emmanuel Scalais; Marc Espeel; Joél Smet; Gert Van Goethem; Rudy Van Coster
Journal:  BMC Clin Pathol       Date:  2009-06-05

10.  Clinical, biochemical, cellular and molecular characterization of mitochondrial DNA depletion syndrome due to novel mutations in the MPV17 gene.

Authors:  Johanna Uusimaa; Julie Evans; Conrad Smith; Anna Butterworth; Kate Craig; Neil Ashley; Chunyan Liao; Janet Carver; Alan Diot; Lorna Macleod; Iain Hargreaves; Abdulrahman Al-Hussaini; Eissa Faqeih; Ali Asery; Mohammed Al Balwi; Wafaa Eyaid; Areej Al-Sunaid; Deirdre Kelly; Indra van Mourik; Sarah Ball; Joanna Jarvis; Arundhati Mulay; Nedim Hadzic; Marianne Samyn; Alastair Baker; Shamima Rahman; Helen Stewart; Andrew Am Morris; Anneke Seller; Carl Fratter; Robert W Taylor; Joanna Poulton
Journal:  Eur J Hum Genet       Date:  2013-05-29       Impact factor: 4.246

View more
  1 in total

1.  Expanding the Spectrum of Polymerase Gamma-Related Ataxia.

Authors:  Harsh Vardhan Gupta; Kayla Karlowski; Tekalign Burka
Journal:  Ann Indian Acad Neurol       Date:  2019-10-25       Impact factor: 1.383

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.